PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 77 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $204,000 | +2.5% | 79,483 | 0.0% | 0.00% | – |
| Q4 2020 | $199,000 | +26.8% | 79,483 | +4.8% | 0.00% | – |
| Q3 2020 | $157,000 | -28.6% | 75,873 | +6.7% | 0.00% | – |
| Q2 2020 | $220,000 | +35.8% | 71,126 | 0.0% | 0.00% | – |
| Q1 2020 | $162,000 | -36.2% | 71,126 | +1.2% | 0.00% | – |
| Q4 2019 | $254,000 | +4.5% | 70,302 | -1.3% | 0.00% | – |
| Q3 2019 | $243,000 | -27.5% | 71,258 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $335,000 | +22.7% | 71,258 | -12.4% | 0.00% | 0.0% |
| Q1 2019 | $273,000 | +26.4% | 81,349 | 0.0% | 0.00% | – |
| Q4 2018 | $216,000 | -51.5% | 81,349 | +2.4% | 0.00% | -100.0% |
| Q3 2018 | $445,000 | +10.4% | 79,464 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $403,000 | -3.1% | 79,464 | +30.3% | 0.00% | 0.0% |
| Q1 2018 | $416,000 | -2.1% | 60,990 | +8.3% | 0.00% | 0.0% |
| Q4 2017 | $425,000 | +37.5% | 56,325 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $309,000 | +0.3% | 53,717 | -11.6% | 0.00% | 0.0% |
| Q2 2017 | $308,000 | – | 60,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |